North American pharmaceutical market focus shifting from prescriber to payer
Following the global economic recession and a slower-than-anticipated recovery, cost-containment measures are shifting the decision-making focus of North America’s pharmaceutical market from the prescriber to the payer, says research and consulting firm GlobalData.
The company’s latest report* states that the global pharmaceutical industry is currently being confronted with intensified obstacles along the path to new product commercialization, with pricing and reimbursement hurdles particularly challenging for the North American market.